Actos lawsuits are being filed in courts around the country by people who allege using Actos caused bladder cancer. In June 2011, the U.S. Food & Drug Administration (FDA) warned that taking the drug for more than a year significantly increased the risk of developing Actos bladder cancer. If you or a loved one took Actos and were diagnosed with bladder cancer, you may be able to file an Actos bladder cancer lawsuit seeking compensation for your pain and suffering.
Wright Schulte LLC, a nationwide law firm focused on obtaining justice for the people, represents the victims of defective drug side effects, including those suffering from Actos bladder cancer. If you or a loved one were diagnosed with bladder cancer that could be tied to Actos, we urge you to contact Wright Schulte LLC for a free, no obligation Actos bladder cancer lawsuit evaluation today.
Actos And Bladder Cancer Side Effect
Actos, known generically as pioglitazone, came on the market in 1999 and is approved to treat type 2 diabetes. Other drugs that contain pioglitazone include ActoPlus Met, ActoPlus Met XR, and Duetact. According to Actos bladder cancer lawsuits, even before it was put on the market, animal studies had indicated pioglitazone could cause bladder tumors in rats. When the FDA approved Actos, it also mandated that Takeda Pharmaceuticals conduct a 10-year study into the bladder-cancer risk associated with pioglitazone.
In September 2010, the FDA announced it was launching a safety review of Actos after interim results of that study indicated long-term use of Actos could increase the risk of bladder cancer. In June 2011, the FDA issued a Drug Safety Communication warning that using Actos for one year increased bladder cancer risks by 40 percent. The FDA ordered that the Warnings and Precautions section of the Actos label be updated to warn of this risk.
Actos Bladder Cancer Symptoms
Bladder cancer is the sixth most common form of cancer, and it is known that type 2 diabetics are at an increased risk for the disease. Common symptoms of bladder cancer include:
- Pain during urination
- Frequent Urinary Tract Infections
- Painful Urination
- Frequent Urination
- Having to Urinate, but without results
- Pain in the lower back around the kidneys
The FDA has warned that Actos should not be used in patients with active bladder cancer, or those with a history of bladder cancer. Actos patients should be sure to tell their doctor if they experience any signs or symptoms that could be indicative of bladder cancer.
Since the FDA began issuing warnings about Actos and bladder cancer, people from around the country have been filing Actos bladder cancer lawsuits alleging Takeda Pharmaceuticals concealed this risk. In December 2011, all federally filed Actos bladder cancer lawsuits were consolidated in the Actos (Pioglitazone) Products Liability Litigation (MDL No. 2299), and transferred to the U.S. District Court, Western District of Louisiana.
Actos Bladder Cancer Lawsuit Evaluations
The attorneys of Wright Schulte LLC work every day to protect the rights of consumers damaged by defective drugs, one case and one client at a time. If you or someone you love took Actos and developed bladder cancer, and you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright Schulte LLC today. For a free, no obligation evaluation of your potential Actos bladder cancer lawsuit, simply fill out the online form on the right, or give Wright Schulte LLC a call, toll-free, at 1-800-399-0795.